Pfizer plans $3.5B in charge cuts as gross sales of Covid merchandise proceed to slip
Pfizer confirmed overdue Friday that it is going to release a company-wide cost-cutting professionalgram this 12 months and subsequent as gross sales of the drugmaker’s Covid vaccine and antiviral slide. The announcement